Press Releases

Date Title and Summary Additional Formats
Toggle Summary Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs
Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs LEXINGTON, Mass and London -- Concert Pharmaceuticals and GlaxoSmithKline (NYSE: GSK) announced
View HTML
Toggle Summary Concert Pharmaceuticals to Participate in the Private Company Forum at the 30th Annual Goldman Sachs Global Healthcare Conference
Concert Pharmaceuticals to Participate in the Private Company Forum at the 30th Annual Goldman Sachs Global Healthcare Conference LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today its participation in the private company forum at the 30th Annual Goldman Sachs Global Healthcare
View HTML
Toggle Summary Concert Pharmaceuticals Granted Patents on Deuterium-Modified Compounds
Concert Pharmaceuticals Granted Patents on Deuterium-Modified Compounds LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that its first patents have been granted by the U.S. Patent and Trademark Office.  These patents relate to specific compounds derived from Concert’s deuterium
View HTML
Toggle Summary Concert Pharmaceuticals Announces Positive Results from Phase I Clinical Study of CTP-347; First Clinical Demonstration of Concert's Technology Platform
First Clinical Demonstration of Concert’s Technology Platform
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference on March 16, 2009
Concert Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference on March 16, 2009 LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present at the Cowen and Company 29th
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12
Concert Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12 LEXINGTON, Mass -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the 27th Annual J.P. Morgan Healthcare Conference, being held at the Westin St.
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
Concert Pharmaceuticals to Present at the Piper Jaffray Health Care Conference LEXINGTON, MA -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the 20th Annual Piper Jaffray Health Care Conference, being held at The New York Palace in New York City.
View HTML
Toggle Summary Concert Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
Concert Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference LEXINGTON, MA -- Concert Pharmaceuticals, Inc. announced today that it will be presenting at the Oppenheimer 19th Annual Healthcare Conference, being held at the Waldorf-Astoria Hotel in New York City.
View HTML
Toggle Summary Concert Pharmaceuticals Announces Preclinical Results Suggesting Potential for Once Daily Dosing of Novel Oxazolidinone Antibiotic; Findings Presented at ICAAC/IDSA
Findings Presented at ICAAC/IDSA
View HTML
Toggle Summary Concert Pharmaceuticals to Present at First Annual Boston Biotech R&D Conference
Concert Pharmaceuticals to Present at First Annual Boston Biotech R&D Conference Lexington, MA – Concert Pharmaceuticals, Inc. today announced that it will be presenting at the 2008 Boston Biotech R&D Conference being held at Harvard Medical School in Cambridge, Massachusetts.  Roger Tung, Ph.D.,
View HTML